Pages that link to "Q29619984"
Jump to navigation
Jump to search
The following pages link to Prognosis of hepatocellular carcinoma: the BCLC staging classification (Q29619984):
Displaying 50 items.
- Management of people with early or very early stage hepatocellular carcinoma: a network meta-analysis (Q24186856) (← links)
- Management of people with intermediate-stage hepatocellular carcinoma: a network meta-analysis (Q24186892) (← links)
- The transcription factor LSF: a novel oncogene for hepatocellular carcinoma (Q24613885) (← links)
- Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma (Q24631107) (← links)
- Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression (Q24647547) (← links)
- Identification of genes conferring resistance to 5-fluorouracil (Q24655818) (← links)
- Immunobiology of hepatocarcinogenesis: Ways to go or almost there? (Q26738293) (← links)
- Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments (Q26743666) (← links)
- Liver resection for intermediate hepatocellular carcinoma (Q26748756) (← links)
- Hepatocellular carcinoma: Review of disease and tumor biomarkers (Q26750796) (← links)
- Liver surgery in cirrhosis and portal hypertension (Q26766055) (← links)
- Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic review (Q26766410) (← links)
- Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma (Q26766707) (← links)
- Hepatocellular Carcinoma in Pakistan: National Trends and Global Perspective (Q26767217) (← links)
- Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future (Q26771246) (← links)
- Hepatobiliary Tumors: Update on Diagnosis and Management (Q26775654) (← links)
- Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis (Q26780309) (← links)
- Hepatocellular Carcinoma and Liver Transplantation: State of the Art (Q26781798) (← links)
- Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging (Q26783895) (← links)
- Grey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: Surgeons' perspective (Q26799052) (← links)
- Current and future treatments for hepatocellular carcinoma (Q26801211) (← links)
- Role of supportive care for terminal stage hepatocellular carcinoma (Q26822263) (← links)
- AEG-1/MTDH/LYRIC in liver cancer (Q26822570) (← links)
- Management of hepatocellular carcinoma in the elderly (Q26827161) (← links)
- Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up (Q26851033) (← links)
- Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation (Q26852105) (← links)
- Management of "very early" hepatocellular carcinoma on cirrhotic patients (Q26864406) (← links)
- Treatment of hepatocellular carcinoma: Steps forward but still a long way to go (Q26865456) (← links)
- Transarterial therapy: an evolving treatment modality of hepatocellular carcinoma (Q26866514) (← links)
- Management of hepatocellular carcinoma with portal vein thrombosis (Q26996578) (← links)
- Diagnostic and therapeutic management of hepatocellular carcinoma (Q26999043) (← links)
- Drug therapy for advanced-stage liver cancer (Q27004410) (← links)
- Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC (Q27011253) (← links)
- Liver transplantation for hepatic tumors: a systematic review (Q27021650) (← links)
- Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma (Q27023495) (← links)
- Current systemic treatment of hepatocellular carcinoma: A review of the literature (Q27026036) (← links)
- Treatment algorithms for managing hepatocellular carcinoma (Q27027923) (← links)
- Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique (Q27690723) (← links)
- Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the Literature (Q28067445) (← links)
- Cancer and liver cirrhosis: implications on prognosis and management (Q28068579) (← links)
- Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016 (Q28072595) (← links)
- Controversies and evidence of hepatic resection for hepatocellular carcinoma (Q28072742) (← links)
- First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response Evaluation (Q28073654) (← links)
- Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines (Q28076314) (← links)
- Update in management of hepatocellular carcinoma in Eastern population (Q28080480) (← links)
- Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma (Q28080514) (← links)
- Staging of hepatocellular carcinoma (Q28081265) (← links)
- Radiation therapy has been shown to be adaptable for various stages of hepatocellular carcinoma (Q28084869) (← links)
- Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicine (Q28087569) (← links)
- Reduction in non-protein respiratory quotient is related to overall survival after hepatocellular carcinoma treatment (Q28487832) (← links)